Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2.
Anna C MavromanoliStefano BarcoWalter AgenoHélène BouvaistMarianne BrodmannClaudio CucciaFrancis CouturaudClaudia DellasKonstantinos DimopoulosDaniel DuerschmiedKlaus EmpenPompilio FaggianoEmile FerrariNazzareno GalièMarcello GalvaniAlexandre GhuysenGeorge GiannakoulasMenno V HuismanDavid JiménezMatija KozakIrene M LangNicolas MeneveauThomas MünzelMassimiliano PalazziniAntoniu Octavian PetrisGiancarlo PiovaccariAldo SalviSebastian SchellongKai-Helge SchmidtFranck VerschurenIrene SchmidtmannGerrit ToengesFrederikus A KlokStavros V Konstantinidesnull nullPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2022)
In the majority of patients with acute intermediate-risk PE switched early to a direct oral anticoagulant, echocardiographic parameters of RV function normalised within 6 days and remained normal throughout the first 6 months. Almost one in four patients, however, continued to have evidence of RV dysfunction over the long term.
Keyphrases
- pulmonary embolism
- inferior vena cava
- mycobacterium tuberculosis
- end stage renal disease
- ejection fraction
- study protocol
- clinical trial
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- left ventricular
- venous thromboembolism
- atrial fibrillation
- prognostic factors
- randomized controlled trial
- patient reported outcomes
- heart failure
- double blind
- left atrial